Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Melatonin reverses H-89 induced spatial memory deficit: Involvement of oxidative stress and mitochondrial function.
Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines.
Late-onset myasthenia gravis. Follow-up of 113 patients diagnosed after age 60.
Infection.
Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis.
Potential Benefit of the Charge-Stabilized Nanostructure Saline RNS60 for Myelin Maintenance and Repair.
An Approach to Enhance Alignment and Myelination of Dorsal Root Ganglion Neurons.
A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis - Rationale and design.
A high-fat diet fed during different periods of life impairs steroidogenesis of rat Leydig cells.
Discovery of a novel JAK3-selective inhibitor: Functional differentiation of JAK3-selective inhibition over pan-JAK or JAK1-selective inhibition.
Inflammatory Th17 Cells Express Integrin αvβ3 for Pathogenic Function.
Mature dendritic cells cause Th17/Treg imbalance by secreting TGF-β1 and IL-6 in the pathogenesis of experimental autoimmune encephalomyelitis.
Long-Term Cost-Effectiveness of Transanal Irrigation in Patients with Neurogenic Bowel Dysfunction.
SCARB2/LIMP2 deficiency in action myoclonus-renal failure syndrome.
Dilutional Hyponatremia during Hysteroscpic Surgery: Prevention and Treatment.
Partial oculomotor nerve palsy in a 7-year-old child.
Autophagy induction stabilizes microtubules and promotes axon regeneration after spinal cord injury.
Dihydroorotate dehydrogenase: A drug target for the development of antimalarials.
Chronic inflammatory demyelinating polyneuropathy variant (Lewis- Sumner syndrome) in HIV.
The association of pathological laughing and crying and cognitive impairment in multiple sclerosis.
GDNF Enhances Therapeutic Efficiency of Neural Stem Cells-Based Therapy in Chronic Experimental Allergic Encephalomyelitis in Rat.
Blockade of chemokine signaling in patients with multiple sclerosis.
Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple Sclerosis.
β-defensin-2 is a responsive biomarker of IL-17A-driven skin pathology in psoriasis.

Pages